Atlas Trials

Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial

Clinical trial NCT03214627 · TERMINATED

Trial details

NCT number
NCT03214627
Sponsor
Vifor Fresenius Medical Care Renal Pharma
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
AnemiaEnd Stage Renal Disease
Start date
2018-12-10
Primary completion
2019-05-21
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.